Skip to content

Testing Mechanisms of Virtual Reality Exposure Therapy for Social Anxiety

Testing Mechanisms of Virtual Reality Exposure Therapy for Social Anxiety

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07437872
Enrollment
45
Registered
2026-02-27
Start date
2026-02-24
Completion date
2028-03-01
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fully Customized Interactions VRET, no Interaction VRET, Scripted Interactions VRET

Brief summary

The purpose of this study is to test mechanisms and processes of virtual reality and augmented reality exposure therapy for social anxiety. There is substantial evidence that virtual reality exposure therapy is an effective treatment for social anxiety. However, it can be difficult to access treatment that needs to be conducted in person. Tests of self-guided (without therapist assistance) virtual reality exposure therapy have had mixed efficacy and tests of augmentation offer an important method to optimize brief interventions. The study objectives are to test a wide range of possible mechanisms and approaches (ranging from single sessions in person to remotely conducted virtual reality exposure therapy) in order to advance the field. The broadness of the proposed research is to provide multiple avenues for inquiry per discussion with IRB chair Dr. Kuo. Depending on the specific line of inquiry some variations will be documented (e.g., multiple consent forms for answering different sub questions of the primary questions listed below).

Interventions

BEHAVIORALExpandXR

An Mixed Reality Exposure Therapy platform for the Apple Vision Pro

Sponsors

Palo Alto University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals at least 18 years of age * Located in the U.S. with sufficient proximity to Mountain View Campus to attend in person visit(s). * Able to give consent * Social Anxiety Disorder based on Structured Clinical Interview AND/OR self-report score cutoff (LSAS \> 47).

Exclusion criteria

* Current Alcohol or Substance Use Disorder (based on self-report) * Current or prior psychotic related or bipolar disorder (based on self-report) * Unstable psychotropic medication (starting/stopping medication in past 6 weeks based on selfreport) * Current cognitive behavioral therapy for social anxiety * Impaired vision such that cannot see in VR headset without glasses (contacts okay)

Design outcomes

Primary

MeasureTime frameDescription
Liebowitz Social Anxiety Scale Self Report VersionBaselineThe Liebowitz Social Anxiety Scale Self Report Version is a 48-item self-report measure of fear and avoidance concerning social interactions and performance situations (e.g., telephoning in public, talking to people in authority). The range of scores is 0-144; higher scores are worse.
Personal Report of Communication Apprehension (PRCA)BaselineThe Personal Report of Communication Apprehension is a 24-item that assesses anxiety related to speaking in a variety of situation. The range of scores is 24-120; higher scores are worse.

Secondary

MeasureTime frameDescription
Speech Anxiety Thoughts InventoryBaselineThe Speech Anxiety Thoughts Inventory is a 23-item self-report measure of assessing the intensity of belief in maladaptive, negative thoughts categorized into two main factors: prediction of poor performance and fear of negative evaluation by the audience. The range of scores is 23-115 with higher scores reflecting greater endorsement of maladaptive thoughts.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026